The novel approach of this peptide represents a significant advance in the care of diabetes mellitus type 2. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide909216.blog-eye.com/42357797/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment